Literature DB >> 22387461

Novel therapeutic approaches to post-infarction remodelling.

Daniela Fraccarollo1, Paolo Galuppo, Johann Bauersachs.   

Abstract

Adverse cardiac remodelling is a major cause of morbidity and mortality following acute myocardial infarction (MI). Mechanical and neurohumoral factors involved in structural and molecular post-infarction remodelling were important targets in research and treatment for years. More recently, therapeutic strategies that address myocardial regeneration and pathophysiological mechanisms of infarct wound healing appear to be useful novel tools to prevent progressive ventricular dilation, functional deterioration, life-threatening arrhythmia, and heart failure. This review provides an overview of future and emerging therapies for cardiac wound healing and remodelling after MI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387461     DOI: 10.1093/cvr/cvs109

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  36 in total

1.  SS31 therapy effectively protects the heart against transverse aortic constriction-induced hypertrophic cardiomyopathy damage.

Authors:  Hung-I Lu; Fan-Yen Lee; Christopher Glenn Wallace; Pei-Hsun Sung; Kuan-Hung Chen; Jiunn-Jye Sheu; Sarah Chua; Meng-Shen Tong; Tien-Hung Huang; Yi-Ling Chen; Pei-Lin Shao; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.

Authors:  Min Xie; Yongli Kong; Wei Tan; Herman May; Pavan K Battiprolu; Zully Pedrozo; Zhao V Wang; Cyndi Morales; Xiang Luo; Geoffrey Cho; Nan Jiang; Michael E Jessen; John J Warner; Sergio Lavandero; Thomas G Gillette; Aslan T Turer; Joseph A Hill
Journal:  Circulation       Date:  2014-01-06       Impact factor: 29.690

3.  Evaluation of biatrial size and functions by different echocardiographic parameters in patients with acute coronary syndromes.

Authors:  Mesut Pinar; Okan Gulel; Zafer Kucuksu; Murat Meric; Mahmut Sahin; Ozcan Yilmaz
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-03       Impact factor: 2.357

4.  MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

Authors:  Lei Xu; Cecelia C Yates; Pamela Lockyer; Liang Xie; Ariana Bevilacqua; Jun He; Cynthia Lander; Cam Patterson; Monte Willis
Journal:  J Mol Cell Cardiol       Date:  2014-10-01       Impact factor: 5.000

5.  Measurement science in the circulatory system.

Authors:  Casey M Jones; Sandra M Baker-Groberg; Flor A Cianchetti; Jeremy J Glynn; Laura D Healy; Wai Yan Lam; Jonathan W Nelson; Diana C Parrish; Kevin G Phillips; Devon E Scott-Drechsel; Ian J Tagge; Jaime E Zelaya; Monica T Hinds; Owen J T McCarty
Journal:  Cell Mol Bioeng       Date:  2014-03       Impact factor: 2.321

Review 6.  Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.

Authors:  Chike C Nwabuo; Ramachandran S Vasan
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

7.  HDAC inhibition helps post-MI healing by modulating macrophage polarization.

Authors:  Denise Kimbrough; Sabina H Wang; Lillianne H Wright; Santhosh K Mani; Harinath Kasiganesan; Amanda C LaRue; Qi Cheng; Satish N Nadig; Carl Atkinson; Donald R Menick
Journal:  J Mol Cell Cardiol       Date:  2018-04-19       Impact factor: 5.000

Review 8.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

9.  PET imaging of cardiac wound healing using a novel [68Ga]-labeled NGR probe in rat myocardial infarction.

Authors:  Jochen Tillmanns; Magdalena Schneider; Daniela Fraccarollo; Jan-Dieter Schmitto; Florian Länger; Dominik Richter; Johann Bauersachs; Samuel Samnick
Journal:  Mol Imaging Biol       Date:  2014-07-11       Impact factor: 3.488

10.  Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice.

Authors:  Sarah E Haskell; Veronica A Peotta; Benjamin E Reinking; Gregory M Hermann; Robert D Roghair
Journal:  J Cardiovasc Pharmacol       Date:  2013-11       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.